Mirko Beljanski’s discoveries have been recently confirmed by another scientific publication. The new article written by John Hall, the scientific advisor to the Beljanski Foundation and James Grutsch, from the Cancer Treatment Centers of America was published in Anti-Aging Therapeutics Volume XIV and describes a Phase I clinical trial showing that RNA fragments prepared by Mirko Beljanski (also known as RealBuild®) support the immune system of cancer patients undergoing chemotherapy.
This special preparation of RNA fragments is a member of the family of natural products developed by Mirko Beljanski. The study demonstrates that the RNAs act as triggers for cell division in bone marrow stem cells, a population that is commonly damaged by chemotherapy treatments. The study confirms that as a result, the white blood cells, including platelets, proliferate and return to normal levels protecting the patient from the risks associated with thrombocytopenia.
Read the full article >>
To help recognize National Ovarian Cancer Awareness, the Beljanski Foundation is very pleased to announce that the NBC “News 4 New York at 7″ with Pei-Sze Cheng has invited both Sylvie Beljanski, Vice-President of the Beljanski Foundation and John Hall, PhD, its Senior Scientific Advisor, to discuss the remarkable results achieved on ovarian cancer cells with the extracts of Pao pereira and Rauwolfia vomitoria first discovered by Mirko Beljanski.
” The history of science is filled with stories of men and women who, with their breakthrough discoveries, challenged the existing powerful interests of their day. These heroes of science (who often became political heroes as well) often demonstrated great courage to face off against extremely well funded, established and profitable cartels like the intertwined interests of the chemical and food industries and the cancer and medical establishments. These scientific pioneers frequently suffered greatly for their courage in advocating truth over traditional theories, however unpopular and unwanted the truth may have been—at least by the most powerful moneyed interests…”
Today, prostate cancer is the second most common cause of cancerous death among men worldwide, in particular throughout Europe and the United States. When prostatic tissue is examined microscopically, cancer is found in 50 percent of males over age 70 and in virtually all males over age 90. Most of the time, such cancers never cause symptoms, but 3 percent of men exhibiting diseased prostate tissue changes die of the malignancy.
Dr Katz from Columbia University said : “The bottom line is that it appears our early
results are reason to be very encouraged by Beljanski’s extracts’ ability to lower PSA and help older men urinate better, too.”